StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) stock

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.92−0.09 (-8.88%)

Close on Nov 17, 2026Market cap $8.70MP/E –Yield –

Cellectar Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cellectar Biosciences's total debt was $0 at Dec 31, 2016. For fiscal 2016 it was $0, down 100.0% from the year before. The highest annual figure on record is $920.94K in fiscal 2010.

Annual total debt

PeriodPeriod endValueChange
FY2016Dec 31, 2016$0-100.0%
FY2015Dec 31, 2015$86.63K-73.8%
FY2014Dec 31, 2014$330.08K-26.6%
FY2013Dec 31, 2013$450.00K0.0%
FY2012Dec 31, 2012$450.00K0.0%
FY2011Dec 31, 2011$450.00K-51.1%
FY2010Dec 31, 2010$920.94K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More Cellectar Biosciences figures

See a number that looks wrong?